Dr Xuyu (Johnny) Liu completed his Bachelor and Master of Biomedical Science at Victoria University, Wellington, NZ in 2012. He then moved to Sydney and conducted his PhD research under the supervision of Professor Richard J Payne in the School of Chemistry at The University of Sydney and graduated in 2016. His PhD research entailed developing new methods for sulfopeptide synthesis and evaluating sulfopeptides’ biological activity. In his postdoctoral work, he worked at Cornell University and École Polytechnique Fédérale de Lausanne (EPFL) under the guidance of Prof Yimon Aye. His postdoctoral research focused on hijacking endogenous lipid electrophile-signalling pathways for precision medicine development. The contribution of this work to anticancer research was recognised by Cornell University, and he was nominated by the university for the Blavatnik Award in 2018.
Dr Liu was awarded the Sydney Cardiovascular Fellowship and joins HRI to start his independent research in developing new chemoproteomic platforms for identification of novel therapeutic targets for cardiovascular disease.